Prognostic factors of septic arthritis of hip in infants and neonates: minimum 5-year follow-up

Clinics in Orthopedic Surgery
Soon Chul LeeSung San Lee

Abstract

The authors conducted the present study to identify clinical and radiological prognostic factors in infants and neonates with septic arthritis of the hip. The authors retrospectively reviewed the records of 31 patients with septic arthritis of the hip. All of the patients were younger than 18 months old. Follow-up periods ranged from 5 to 17 years. The following potential variables for predicting the prognosis were included in the assessment: gender, age, underlying diseases, duration of symptoms, changes of hip joint in X-ray, concomitant osteomyelitis, elevation of erythrocyte sedimentation rate and C-reactive protein, sepsis, pus drainage, synovial fluid culture, and infecting organisms. Clinical and radiological prognoses were analyzed at the final follow-up. Univariate analysis demonstrated that radiological prognoses were poorer in patients who had underlying diseases, a longer duration of symptoms, and pus drainage. However, on multivariate analysis, only the variable-duration of symptoms-was found to be statistically related with a poor radiological prognosis. Although poor prognosis for patients with several underlying diseases and radiological changes has already been established, a favorable outcome might be expected...Continue Reading

References

Aug 23, 1976·JAMA : the Journal of the American Medical Association·J B HowardJ D Nelson
May 1, 1997·Clinical Orthopaedics and Related Research·D M KleinJ L Teicher
Nov 4, 2000·Pediatrics International : Official Journal of the Japan Pediatric Society·H CaksenH Per
Oct 16, 2001·Archives of Orthopaedic and Trauma Surgery·C E ChenC J Wang
Nov 8, 2002·Pediatrics International : Official Journal of the Japan Pediatric Society·Sevki KabakNazmi Narin
Jan 8, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Brahm GoldsteinUNKNOWN International Consensus Conference on Pediatric Sepsis
Jan 30, 2007·The Journal of Bone and Joint Surgery. British Volume·T R NunnP D Rollinson
Apr 30, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Yoshiaki YamagishiMasashi Shiomi
Jun 9, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Muslim M Al SaadiYoussef S Al Eissa
Sep 2, 2009·The Journal of Bone and Joint Surgery. British Volume·S-N KangM Ramachandran
Jan 28, 2010·Journal of Pediatric Orthopedics·Mohan V BelthurJacob Weinberg
Aug 3, 2010·The American Journal of Emergency Medicine·Timothy P YoungLance Brown

❮ Previous
Next ❯

Citations

Jul 15, 2017·The Pediatric Infectious Disease Journal·Jesús Saavedra-LozanoAnton LeMair
Sep 11, 2019·Journal of Pediatric Orthopedics. Part B·Michael Seungcheol KangSoo-Sung Park
Sep 6, 2020·Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews·K Aaron ShawUNKNOWN CORTICES Study Group
Jul 19, 2017·International Orthopaedics·Sung-Weon JungSeong-Wook Yang
Dec 5, 2020·The Journal of the American Academy of Orthopaedic Surgeons·Mehmet ErkilincR Justin Mistovich
Dec 19, 2020·Frontiers in Pediatrics·Nora ManzUlrich Heininger
Nov 3, 2020·Journal of Pediatric Orthopedics. Part B·Soon Hyuck LeeWoo Young Jang

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
ESR

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved